Prophylactic cranial irradiation in resected small cell lung cancer: A systematic review with meta-analysis
Yang Yang, Danhong Zhang, Xia Zhou, Wuan Bao, Yu-Meng Ji, Liming Sheng, Lei Cheng, Ying Chen, Xianghui Du, Guoqin Qiu · Journal of Cancer · 2017
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · review · 2017
Abstract
Background: The use of PCI in early operable patients with small cell lung cancer (SCLC) is still controversial.Therefore, we conducted a systematic review with meta-analysis to investigate the effects of PCI in resected SCLC patients.Methods: Relevant studies were identified from PubMed and EMBASE databases, the pooled hazard risks were obtained by the random-effects model.We also analyzed the brain metastasis (BM) risk in p-stage I patients without PCI.Results: Five retrospective studies were identified and a total of 1691 patients were included in our analysis, 315 of them received PCI.For all the resected patients, PCI was associated with improved overall survival (HR: 0.52, 95% CI: 0.33-0.82),and reduced brain metastasis risk (RR: 0.50, 95%CI: 0.32-0.78).However, with regard to p-stage I patients, no survival benefit was brought by PCI (HR: 0.87, 95% CI: 0.34-2.24).Moreover, the pooled analysis of 7 studies found that the 5-year brain metastasis risk was relatively low (12%, 95% CI: 8%-17%) for p-stage I patients without PCI.Conclusions: PCI might be associated with a favorable survival advantage and reduced BM risk in complete resected SCLC patients, except for p-stage I patients.
Open the resolved locator · 10.7150/jca.21465
Metadata licence: OpenAlex metadata (CC0)